WESTCHESTER COUNTY LIFE SCIENCES UPDATE

Retia Medical and The JANZ Corporation Announce Strategic Partnership Agreement

White Plains' Retia Medical, a leading provider of advanced hemodynamic monitoring solutions, and The JANZ Corporation are pleased to announce a strategic agreement aimed at expanding the availability of Retia Medical’s hemodynamic monitor. The JANZ Corporation is a Service-Disabled Veteran Owned Small Business serving the U.S. Government hospital to home market with an array of medical equipment, supplies, and services since 1999.

Retia Medical's flagship product, the Argos™ Cardiac Output Monitor, is a minimally invasive, user-friendly device that provides clinicians a consistently accurate tool to optimize patient management in critical care settings and detect shock before it becomes an emergency. The company is a valuable member of Westchester's life sciences ecosystem and participated in the Westchester County Office of Economic Development's exclusive tour earlier this year.

The JANZ Corporation's strong distribution network and established presence in the global medical device market will significantly enhance the availability of the Argos™ Monitor to military hospitals around the world. This partnership aims to also accelerate the adoption of the Argos™ Cardiac Output Monitor, ultimately benefiting patients and healthcare providers by enabling better patient outcomes and improved efficiency in the delivery of care.

Read more

Want to Take Your Venture to the Next Level?

Apply to the Westchester County Biosciences Accelerator

The Westchester County Biosciences Accelerator (WCBA) has opened up the application period for the program's 2024 cohort. Not sure what to expect from a biotech accelerator? Join the WCBA team for an upcoming info session to learn more about the program, including how and when to submit an application, program structures, how to make your application standout and what you stand to gain from becoming a 2024 venture.

Upcoming Spring 2024 Cohort Information Session

Date: July 18

Time: 10:00 AM

Register

Cognition Activates First Site for Enrolment in Study of Alzheimer’s Therapy

Purchase’s Cognition Therapeutics and the Alzheimer’s Clinical Trials Consortium (ACTC) have activated the first site for enrolling patients in the Phase II START study of CT1812 to treat early Alzheimer’s disease (AD). The study will be carried out at around 50 sites in North America including more than 30 premier academic institutions which are part of the ACTC’s network.

Among the 50 sites, the University of Kentucky Sanders-Brown Center on Aging (SBCoA) is the first site activated for enrollment. The placebo-controlled, randomized study intends to enroll up to 540 adults with early AD and elevated beta-amyloid (Aβ).

Patients will be randomized to receive either daily doses of CT1812 orally or a placebo for 18 months.

Read more

UPCOMING EVENTS

Westchester County Biosciences Accelerator

2024 Program Information Session

Date: July 18

Time: 10:00 AM

Register

FuzeHUB Manufacturing Webinar Series:

Critical Stage Webinar

You have performed proof-of-concept testing and your product shows promise, but you need to refine the product, scale up processes (without lowering quality), and get the message out to more customers (potentially in new markets or industries). Find out where to go for help with things like: mid-volume production, testing/validation, developing a more robust supply chain, getting assistance with workforce development, marketing, and funding.

Date: July 19

Time: 11:00 AM

Register

CNYBAC Concept to Commercialization Virtual Series

One-Hour Q&A on SAFE and Convertible Note Rounds

with Skylight Law

Michael Byrd, Co-Founder of Skylight Law, returns for an open session to discuss SAFE and Convertible Note funding.

Date: July 13

Time: 3:00 PM

Register

Challenges in Bioentrepreneurship

An interview session with CEO and Co-founder of CMTx Biotech, Joseph Scaduto. Register early for this can't-miss event and be sure to come with your questions!

Date: July 17

Time: 3:00 PM

Register

Innovation Through Law:

The Importance of Early-Stage IP, Regulatory and Market Research

The Innovation Law Center (ILC) provides legal research, education, and information useful to assessing the commercialization prospects for new technology. The research is also useful when bringing new technologies from an early stage to investment ready. When it comes to commercializing new technology, knowing what you don’t know is half the battle. The ILC provides entrepreneurs and companies research important to identifying potential IP, market, and regulatory challenges and devise effective strategies to successfully bring that technology to market.

Date: July 25

Time: 2:00 PM

Register

Have good news to share with

Westchester’s life sciences ecosystem?

Please let us know.

Email lifesciences@westchestergov.com.